Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidism

Am J Surg. 2013 Mar;205(3):269-73; discussion 273. doi: 10.1016/j.amjsurg.2013.01.001. Epub 2013 Jan 22.

Abstract

Background: In hyperparathyroidism, dual-phase technetium-99m sestamibi scintigraphy is important for parathyroid adenoma localization. We hypothesized that reviewing early-phase scans can increase localization in patients with primary hyperparathyroidism (PHPT).

Methods: We reviewed our prospectively maintained database for patients with sestamibi scans before parathyroidectomy for PHPT from 2001 to 2011. Early-phase scans were read and compared with the location of the gland(s) removed at operation.

Results: Of 902 patients identified, radiologists read 693 scans as positive. Of 209 negative scans, 141 (67%) were positive in the early phase; 135 (96%) correctly identified the side of the adenoma. Using radiologist reads, 35% of patients with negative scans and 41% of patients with falsely localized glands required bilateral exploration compared with 5% of patients with correctly localized glands.

Conclusions: A review of early scans in patients with negative imaging increases accurate adenoma localization and allows for minimally invasive operations in more patients.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Chi-Square Distribution
  • Child
  • Female
  • Humans
  • Hyperparathyroidism, Primary / diagnostic imaging*
  • Hyperparathyroidism, Primary / surgery
  • Male
  • Middle Aged
  • Parathyroid Neoplasms / diagnostic imaging*
  • Parathyroid Neoplasms / surgery
  • Parathyroidectomy
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Retrospective Studies
  • Technetium Tc 99m Sestamibi*
  • Treatment Outcome

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi